Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck

NCT00096174 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: cetuximab C225
DRUG: cisplatin
RADIATION: radiation therapy

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]